Zimmer Biomet (ZBH) Q1 2025 10-Q Quarterly Report

Filed: May 5, 2025Period ending Mar 31, 2025

Health Care

Orthopedic, Prosthetic & Surgical Appliances & SuppliesSEC EDGAR

Zimmer Biomet (ZBH) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 5, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

Zimmer Biomet Q1 2025 10-Q Analysis

Risk Factors

• No new or changed risk factors disclosed compared to 2024 Form 10-K
• Continued risks include product liability and recall exposure impacting operations and financial condition

+3 more insights

Zimmer Biomet Q1 2025 Quarterly Financials
XBRL

Revenue

$1.9B

▲ +1.1% YoY

Net Income

$182M

▲ +5.6% YoY

Net Margin

9.5%

▲ +41bp YoY

Source: XBRL data from Zimmer Biomet Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Zimmer Biomet Quarterly Reports

Q3 2025 10-Q

Get deeper insights on Zimmer Biomet

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.